10:14 ET -- Caribou Biosciences is one of the most mentioned companies in the U.S. across all news items in the last 12 hours, according to Factiva data. The clinical-stage biopharmaceutical company received a $25 million equity investment from drug giant Pfizer at a 31% premium, sending its shares up nearly 60%. Dow Jones & Co. owns Factiva. (colin.kellaher@wsj.com)

(END) Dow Jones Newswires

July 06, 2023 10:29 ET (14:29 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
From May 2024 to Jun 2024 Click Here for more Caribou Biosciences Charts.
Caribou Biosciences (NASDAQ:CRBU)
Historical Stock Chart
From Jun 2023 to Jun 2024 Click Here for more Caribou Biosciences Charts.